Article
MTR D919G variant is associated with prostate adenocarcinoma risk: evidence based on 51106 subjects.
European review for medical and pharmacological sciences - 1 Aug 2020
Jing H-W, Yin L, Yu H-Y, Zuo L, Liu T
Abstract excerpt
OBJECTIVE: Several case-control studies have identified the association of the D919G polymorphism of the methionine synthase (MTR) gene with the risk of prostate adenocarcinoma (PRAD). However, the results were inconclusive. MATERIALS AND METHODS: Odds ratios (ORs) with corresponding 95% confidence intervals (95% CIs) were evaluated to assess the correlation between MTR D919G variant and PRAD risk. In addition,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
